0000950123-16-022022.txt : 20161114
0000950123-16-022022.hdr.sgml : 20161111
20161114081612
ACCESSION NUMBER: 0000950123-16-022022
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20160930
FILED AS OF DATE: 20161114
DATE AS OF CHANGE: 20161114
EFFECTIVENESS DATE: 20161114
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: SV Life Sciences Advisers, LLC
CENTRAL INDEX KEY: 0001587143
IRS NUMBER: 861154144
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16271
FILM NUMBER: 161990743
BUSINESS ADDRESS:
STREET 1: ONE BOSTON PLACE
STREET 2: 201 WASHINGTON STREET, SUITE 3900
CITY: BOSTON
STATE: MA
ZIP: 02108
BUSINESS PHONE: 617-367-8100
MAIL ADDRESS:
STREET 1: ONE BOSTON PLACE
STREET 2: 201 WASHINGTON STREET, SUITE 3900
CITY: BOSTON
STATE: MA
ZIP: 02108
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
false
0001587143
XXXXXXXX
09-30-2016
09-30-2016
SV Life Sciences Advisers, LLC
ONE BOSTON PLACE
201 WASHINGTON STREET, SUITE 3900
BOSTON
MA
02108
13F HOLDINGS REPORT
028-16271
Y
The filing of this report shall not be deemed an admission, for purposes of Section 13(f), 13(d), 13(g), or 16(a) under the Securities Exchange Act of 1934, as amended, and the rules thereunder, or for any other purpose, that the Reporting Manager or any other person (including Other Managers or Other Included Managers named herein) is the beneficial owner of any securities. SV Life Sciences Advisers, LLC, a Delaware limited liability company ("Advisers"), is an institutional investment manager subject to Section 13(f) of the Securities Exchange Act of 1934 and the rules promulgated thereunder. SV Life Sciences Fund IV, L.P. ("SVLS IV LP") and SV Life Sciences Fund IV Strategic Partners, L.P. ("Strategic Partners IV" and together with SVLS IV LP, the "Fund IV Entities"), and International Life Sciences Fund III (LP 1), L.P. ("ILSF LP1"), International Life Sciences Fund III Co- Investment, L.P. ("ILSF Co-Invest"), and International Life Sciences Fund III Strategic Partners, L.P. ("ILSF Strategic" and together with ILSF LP1 and ILSF Co-Invest, the "Fund III Entities"), and SV Life Sciences Fund V, L.P. ("SVLS V LP") and SV Life Sciences Fund V Strategic Partners, L.P. ("Strategic Partners V" and together with SVLS V LP, the "Fund V Entities"), which are each Delaware limited partnerships (the Fund IV Entities, the Fund III Entities and the Fund V Entities together, the "Funds"), directly own certain security positions reported by Advisers, which is the investment adviser of the Funds. SV Life Sciences Fund IV (GP), L.P., a Delaware limited partnership ("SVLS IV GP") is the general partner of the Fund IV Entities, and SVLSF IV, LLC, a Delaware limited liability company is the general partner of SVLS IV GP. Certain of the security positions reported by Advisers are also being reported by SVLS IV GP and SVLSF IV, LLC. Each of SVLS IV GP, SVLSF IV, LLC and Advisers may be deemed to share voting power and control over the shares held by the Fund IV Entities. Advisers may be deemed to share voting power and control over the shares held by the Fund III Entities and the Fund V Entities. Each of SVLS IV GP, SVLSF IV, LLC and Advisers disclaim beneficial ownership of the shares held by the Funds except to the extent of any pecuniary interest therein.
Denise W. Marks
CFO
(617) 367-8100
/s/ Denise W. Marks
Boston
MA
11-14-2016
2
6
130196
false
1
028-16272
SVLSF IV, LLC
2
028-16273
SV Life Sciences Fund IV (GP), L.P.
INFORMATION TABLE
2
form13fInfoTable.xml
INFORMATION TABLE FOR FORM 13F
TRANSENTERIX INC
COM NEW
89366M201
12754
7546692
SH
OTR
1,2
0
7546692
0
OCULAR THERAPEUTIX INC
COM
67576A100
13277
1932607
SH
OTR
1,2
0
1932607
0
ENTELLUS MED INC
COM
29363K105
77398
3489533
SH
OTR
1,2
0
3489533
0
CATABASIS PHARMACEUTICALS IN
COM
14875P107
17602
2857667
SH
OTR
0
2857667
0
LOMBARD MED INC
COM
G55598109
1199
1275779
SH
OTR
1,2
0
1275779
0
RAPTOR PHARMACEUTICAL CORP
COM
75382F106
7966
888132
SH
OTR
1,2
0
888132
0